Next generation sequencing, structural biology, pharmacology & drug design, and biomedical informatics applied in the context of aggressive blood cancer
Education
verified_user
0% verified
Master of Philosophy (MPhil, Computational Biology and Bioinformatics
Columbia University
Jan 2010 - Dec 2012(3 years)
Doctor of Philosophy (Ph.D, Genome Sciences/Genomics
Columbia University
Jan 2009 - Dec 2014(6 years)
Columbia University in the City of New York
Columbia University in the City of New York
Jan 2009 - Jan 2014(5 years 1 month)
Master of Arts (M.A, Pharmacology and Molecular Signaling
Columbia University
Jan 2009 - Dec 2010(2 years)
Bachelor of Science (B.S, Biology
The College of New Jersey
Jan 2005 - Dec 2009(5 years)
Awards
verified_user
0% verified
M
MIG Scholars Program
Publications
verified_user
0% verified
N
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Nature Genetics
Jan 2014
L
Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methyla
Leukemia
Jan 2013
N
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Nature Medicine
Jan 2013
m
Emergence of Fatal Avian Influenza in New England Harbor Seals
mBio
Jan 2012
N
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL
Nature Medicine
Jan 2012
C
Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia
Cancer Cell
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia